(June 18, 2019, 1:38 PM EDT) -- BOSTON — A Massachusetts federal judge overseeing the Zofran birth defect multidistrict litigation on June 13 remanded a case for a second time after finding under the voluntary-involuntary doctrine that the plaintiffs did not voluntarily dismiss a local hospital and open the door for removal to a federal court (In Re: Zofran [Ondansetron] Products Liability Litigation, [Thomas Brown, et al. v. GlaxoSmithKline LLC, No. 19-10647], No. 15-md-2657, D. Mass., 2019 U.S. Dist. LEXIS 99811)....